Annexon Inc
ANNX·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$4.19
Today
+1.7%
YTD
-16.2%
About
Annexon, Inc. was founded in 2011 and is based in San Francisco, California. An American clinical-stage biopharmaceutical company, it is engaged in developing novel therapies for autoimmune and neurodegenerative diseases. Annexon trades under the ticker ANNX on the Vienna Stock Exchange. Add this instrument to your watchlist to stay up to date on the ANNX price chart.
Price chart
Closing price history for ANNX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-3.65
P/S (TTM)0.00
P/B (TTM)3.93
Market cap$794.34M
Cap tierSmall-cap
Industry avg P/E-7.37
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-105.26%
ROA-79.38%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$1.15
Free cash flow$-193.22M
Total debt$24.65M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.33
Employees96
Next earnings9 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.